Ellevest, Inc. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,943
+94.3%
233
+142.7%
0.00%
Q2 2022$1,00096
+3100.0%
0.00%
Q1 2022$030.0%0.00%
Q4 2021$0
-100.0%
3
-94.8%
0.00%
Q3 2021$1,0000.0%58
+34.9%
0.00%
Q2 2021$1,00043
+1333.3%
0.00%
Q1 2021$030.0%0.00%
Q4 2020$03
-90.3%
0.00%
Q3 2020$031
+63.2%
0.00%
Q2 2020$0190.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders